Biomedical applications and safety issues of gold nanoparticles

Toxicology and Environmental Health Sciences

Volumn 4, Issue 1, 2012, Pages 1-8

  Arai, Yoshie ^a   Jee, Sun Young ^a   Kim, Seong Min ^a   Kwon, Youngeun ^a   Jang, Wonhee ^a  

^a Dongguk University   (South Korea)

Author keywords

Gold nanoparticle; Gold nanorod; Gold nanoshell; Gold nanosphere; Nanotoxicology

Indexed keywords

GOLD NANOPARTICLE; KETOCONAZOLE; MACROGOL; MAGNETIC NANOPARTICLE; NANOROD; NANOSHELL; NANOSPHERE; PHOSPHATIDYLCHOLINE; TITANIUM DIOXIDE;

ANTIMICROBIAL ACTIVITY; APOPTOSIS; BIOSAFETY; BLOOD BRAIN BARRIER; CANCER THERAPY; CARDIOVASCULAR SYSTEM; CELL DEATH; CELL VIABILITY; CYTOTOXICITY; DRUG DELIVERY SYSTEM; ENVIRONMENTAL EXPOSURE; HEAD AND NECK TUMOR; HUMAN; HYPERTHERMIA; IMAGING; INFLAMMATION; LUNG ALVEOLUS MACROPHAGE; NANOMEDICINE; NANOTOXICOLOGY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OXIDATIVE STRESS; PHAGOCYTOSIS; PHASE 1 CLINICAL TRIAL (TOPIC); RADIOGRAPHY; REVIEW; SENSOR; THYROID CANCER; TRANSMISSION ELECTRON MICROSCOPY;

EID: 84873265027     PISSN: 20059752     EISSN: 22337784     Source Type: Journal    
DOI: 10.1007/s13530-012-0111-z     Document Type: Review

References (106)

1. Oberdörster, G., Ferin, J. & Lehnert, B. E. Correlation between particle size, in vivo particle persistence, and lung injury. Environ. Health Perspect. 102Suppl 5, 173-179 (1994).
2. Nel, A., Xia, T., Madler, L. & Li, N. Toxic potential of materials at the nanolevel. Science311, 622-627 (2006).
3. Oberdörster, G., Ferin, J., Gelein, R., Soderholm, S. C. & Finkelstein, J. Role of the alveolar macrophage in lung injury: studies with ultrafine particles. Environ. Health Perspect. 97, 193-199 (1992).
4. Tran, C. L. et al. Inhalation of poorly soluble particles. II. Influence of particle surface area on inflammation and clearance. Inhal. Toxicol. 12, 1113-1126 (2000).
5. Ahn, H. Y. & Park, Y. J. Incidence and clinical characteristics of thyroid cancer in Korea. Korean J. Med. 77, 537-542 (2009).
6. Bacsi, I. et al. Alteration of cylindrospermopsin production in sulfate- or phosphate-starved cyanobacterium Aphanizomenon ovalisporum. FEMS Microbiol. Lett. 259, 303-310 (2006).
7. Park, K. S. Toxicity of nanomaterials and strategy of risk assessment. J. Eeviron. Toxicol. 20, 259-271 (2005).
8. Han, G., Ghosh, P. & Rotello, V. M. Multi-functional gold nanoparticles for drug delivery. Adv. Exp. Med. Biol. 620, 48-56 (2007).
9. Jain, K. K. Applications of nanobiotechnology in clinical diagnostics. Clin. Chem. 53, 2002-2009 (2007).
10. Colvin, V. L. The potential environmental impact of engineered nanomaterials. Nat. Biotechnol. 21, 1166-1170 (2003).
11. Klabunde, K. J. & Richards, R. M. in Nanoscale materials in chemistry. 2th edn (John wiley & Sons, New Jersey, 2009).
12. Ferrari, M. Cancer nanotechnology: opportunities and challenges. Nat. Rev. Cancer5, 161-171 (2005).
13. Rosi, N. L. & Mirkin, C. A. Nanostructures in biodiagnostics. Chem. Rev. 105, 1547-1562 (2005).
14. Han, G., Ghosh, P. & Rotello, V. M. Functionalized gold nanoparticles for drug delivery. Nanomedicine (Lond)2, 113-123 (2007).
15. Jain, P. K., Huang, X., El-Sayed, I. H. & El-Sayed, M. A. Noble metals on the nanoscale: optical and photothermal properties and some applications in imaging, sensing, biology, and medicine. Acc. Chem. Res. 41, 1578-1586 (2008).
16. Murphy, C. J. et al. Gold nanoparticles in biology: beyond toxicity to cellular imaging. Acc. Chem. Res. 41, 1721-1730 (2008).
17. Jain, S., Hirst, D. G. & O'sullivan, J. M. Gold nanoparticles as novel agents for cancer therapy. Br. J. Radiol. 85, 101-113 (2012).
18. Sardar, R., Funston, A. M., Mulvaney, P. & Murray, R. W. Gold nanoparticles: past, present, and future. Langmuir25, 13840-13851 (2009).
19. Kang, S. K. et al. Preparation of gold nanorods and increase of yield. Theo. Appl. Chem. Eng. 8, 4786-4789 (2002).
20. Holsapple, M. P. & Lehman-McKeeman, L. D. Forum series: research strategies for safety evaluation of nanomaterials. Toxicol. Sci. 87, 315 (2005).
21. Oberdörster, G., Oberdörster, E. & Oberdörster, J. Nanotoxicology: an emerging discipline evolving from studies of ultrafine particles. Environ. Health Perspect. 113, 823-839 (2005).
22. Xie, Y. et al. Aerosolized ZnO nanoparticles induce toxicity in alveolar type II epithelial cells at the airliquid interface. Toxicol. Sci. 125, 450-461 (2012).
23. Gojova, A. et al. Induction of inflammation in vascular endothelial cells by metal oxide nanoparticles: effect of particle composition. Environ. Health Perspect. 115, 403-409 (2007).
24. Elder, A. C., Gelein, R., Finkelstein, J. N., Cox, C. & Oberdörster, G. Pulmonary inflammatory response to inhaled ultrafine particles is modified by age, ozone exposure, and bacterial toxin. Inhal. Toxicol. 12Suppl 4, 227-246 (2000).
25. Takenaka, S. et al. Pulmonary and systemic distribution of inhaled ultrafine silver particles in rats. Environ. Health Perspect. 109Suppl 4, 547-551 (2001).
26. Soto, K., Garza, K. M. & Murr, L. E. Cytotoxic effects of aggregated nanomaterials. Acta Biomater. 3, 351-358 (2007).
27. Nemmar, A. et al. Ultrafine particles affect experimental thrombosis in an in vivo hamster model. Am. J. Respir. Crit. Care Med. 166, 998-1004 (2002).
28. Bitner, A., Fialkowski, M., Smoukov, S. K., Campbell, C. J. & Grzybowski, B. A. Amplification of changes of a thin film's macromolecular structure into macroscopic reaction-diffusion patterns. J. Am. Chem. Soc. 127, 6936-6937 (2005).
29. Simeonova, P. P., Opopol, N. & Luster, M. I. in Nanotechnology-toxicological issues and environment safety (NATO Science for Peace and Security Programme, Bulgaria, 2006).
30. Kreuter, J. et al. Apolipoprotein-mediated transport of nanoparticle-bound drugs across the blood-brain barrier. J. Drug Target10, 317-325 (2002).
31. Oberdörster, G. et al. Translocation of inhaled ultrafine particles to the brain. Inhal. Toxicol. 16, 437-445 (2004).
32. Sarin, H. et al. Effective transvascular delivery of nanoparticles across the blood-brain tumor barrier into malignant glioma cells. J. Transl. Med. 6, 80 (2008).
33. Sonavane, G., Tomoda, K. & Makino, K. Biodistribution of colloidal gold nanoparticles after intravenous administration: effect of particle size. Colloids Surf. B Biointerfaces66, 274-280 (2008).
34. Teow, Y., Asharani, P. V., Hande, M. P. & Valiyaveettil, S. Health impact and safety of engineered nanomaterials. Chem. Commun. (Camb)47, 7025-7038 (2011).
35. Sun, D., Meng, T. T., Loong, T. H. & Hwa, T. J. Removal of natural organic matter from water using a nano-structured photocatalyst coupled with filtration membrane. Water Sci. Technol. 49, 103-110 (2004).
36. Pope, C. A., 3rd et al. Cardiovascular mortality and long-term exposure to particulate air pollution: epidemiological evidence of general pathophysiological pathways of disease. Circulation109, 71-77 (2004).
37. Nurkiewicz, T. R. et al. Nanoparticle inhalation augments particle-dependent systemic microvascular dysfunction. Part. Fibre Toxicol. 5, 1 (2008).
38. Drbohlavova, J. et al. Preparation and properties of various magnetic nanoparticles. Sensors9, 2352-2362 (2009).
39. Lok, C. N. et al. Proteomic analysis of the mode of antibacterial action of silver nanoparticles. J. Proteome. Res. 5, 916-924 (2006).
40. Gogoi, S. K. et al. Green fluorescent protein-expressing Escherichia coli as a model system for investigating the antimicrobial activities of silver nanoparticles. Langmuir22, 9322-9328 (2006).
41. Kim, J. S. et al. Antimicrobial effects of silver nanoparticles. Nanomedicine3, 95-101 (2007).
42. Bae, E. J., Lee, J. J., Kim, Y. H., Choi, Y. H. & Yi, J. H. Sample Preparation and Analysis of Physico-Chemical Properties for Safety Assessment of Manufactured Nanomaterials. J. Kor. Soc. Env. Analy. 12, 59-73 (2009).
43. Hu, W. K., Gao, X. P., Geng, M. M., Gong, Z. X. & Noreus, D. Synthesis of CoOOH nanorods and application as coating materials of nickel hydroxide for high temperature Ni-MH cells. J. Phys. Chem. B109, 5392-5394 (2005).
44. Heyes, C. D. & El-Sayed, M. A. Proton transfer reactions in native and deionized bacteriorhodopsin upon delipidation and monomerization. Biophys. J. 85, 426-434 (2003).
45. Huang, X., El-Sayed, I. H., Qian, W. & El-Sayed, M. A. Cancer cell imaging and photothermal therapy in the near-infrared region by using gold nanorods. J. Am. Chem. Soc. 128, 2115-2120 (2006).
46. Sandeep, P. & Bisht, P. B. Effect of adsorbed concentration on the radiative rate enhancement of photoexcited molecules embedded in single microspheres. J. Chem. Phys. 123, 204713 (2005).
47. Marinakos, S. M., Chen, S. & Chilkoti, A. Plasmonic detection of a model analyte in serum by a gold nanorod sensor. Anal. Chem. 79, 5278-5283 (2007).
48. Yu, C. & Irudayaraj, J. Multiplex biosensor using gold nanorods. Anal. Chem. 79, 572-579 (2007).
49. Hirsch, L. R. et al. Nanoshell-mediated near-infrared thermal therapy of tumors under magnetic resonance guidance. Proc. Natl. Acad. Sci. USA100, 13549-13554 (2003).
50. Huang, X., El-Sayed, I. H., Qian, W. & El-Sayed, M. A. Cancer cells assemble and align gold nanorods conjugated to antibodies to produce highly enhanced, sharp, and polarized surface Raman spectra: a potential cancer diagnostic marker. Nano. Lett. 7, 1591-1597 (2007).
51. Norman, R. S., Stone, J. W., Gole, A., Murphy, C. J. & Sabo-Attwood, T. L. Targeted photothermal lysis of the pathogenic bacteria, Pseudomonas aeruginosa, with gold nanorods. Nano. Lett. 8, 302-306 (2008).
52. Tong, L. et al. Gold nanorods mediate tumor cell death by compromising membrane integrity. Adv. Mater. 19, 3136-3141 (2007).
53. Podsiadlo, P. et al. Gold nanoparticles enhance the anti-leukemia action of a 6-mercaptopurine chemotherapeutic agent. Langmuir24, 568-574 (2008).
54. Shukla, R. et al. Biocompatibility of gold nanoparticles and their endocytotic fate inside the cellular compartment: a microscopic overview. Langmuir21, 10644-10654 (2005).
55. Park, J. H., von Maltzahn, G., Ruoslahti, E., Bhatia, S. N. & Sailor, M. J. Micellar hybrid nanoparticles for simultaneous magnetofluorescent imaging and drug delivery. Angew Chem. Int. Ed. Engl. 47, 7284-7288 (2008).
56. Rosi, N. L. et al. Oligonucleotide-modified gold nanoparticles for intracellular gene regulation. Science312, 1027-1030 (2006).
57. Ow Sullivan, M. M., Green, J. J. & Przybycien, T. M. Development of a novel gene delivery scaffold utilizing colloidal gold-polyethylenimine conjugates for DNA condensation. Gene Ther. 10, 1882-1890 (2003).
58. Sandhu, K. K., McIntosh, C. M., Simard, J. M., Smith, S. W. & Rotello, V. M. Gold nanoparticlemediated transfection of mammalian cells. Bioconjug Chem13, 3-6 (2002).
59. El-Sayed, I. H., Huang, X. & El-Sayed, M. A. Selective laser photo-thermal therapy of epithelial carcinoma using anti-EGFR antibody conjugated gold nanoparticles. Cancer Lett. 239, 129-135 (2006).
60. El-Sayed, I. H. Nanotechnology in head and neck cancer: the race is on. Curr. Oncol. Rep. 12, 121-128 (2010).
61. Prudhomme, M. et al. Interstitial diode laser hyperthermia in the treatment of subcutaneous tumor. Lasers Surg Med. 19, 445-450 (1996).
62. Seki, T. et al. Percutaneous microwave coagulation therapy for patients with small hepatocellular carcinoma: comparison with percutaneous ethanol injection therapy. Cancer85, 1694-1702 (1999).
63. Singletary, S. E. et al. Radiofrequency ablation of early-stage invasive breast tumors: an overview. Cancer J. 8, 177-180 (2002).
64. Tempany, C. M. et al. MR imaging-guided focused ultrasound surgery of uterine leiomyomas: a feasibility study. Radiology226, 897-905 (2003).
65. Huang, X., Jain, P. K., El-Sayed, I. H. & El-Sayed, M. A. Plasmonic photothermal therapy (PPTT) using gold nanoparticles. Lasers Med. Sci. 23, 217-228 (2008).
66. Cherukuri, P. & Curley, S. A. Use of nanoparticles for targeted, noninvasive thermal destruction of malignant cells. Methods Mol. Biol. 624, 359-373 (2010).
67. O'Neill, K. L., Fairbairn, D. W., Smith, M. J. & Poe, B. S. Critical parameters influencing hyperthermiainduced apoptosis in human lymphoid cell lines. Apoptosis3, 369-375 (1998).
68. Rong, Y. & Mack, P. Apoptosis induced by hyperthermia in Dunn osteosarcoma cell line in vitro. Int. J. Hyperthermia. 16, 19-27 (2000).
69. Weissleder, R. A clearer vision for in vivo imaging. Nat. Biotechnol. 19, 316-317 (2001).
70. Stern, J. M. et al. Efficacy of laser-activated gold nanoshells in ablating prostate cancer cells in vitro. J. Endourol. 21, 939-943 (2007).
71. Lee, J. J. et al. Public and experts perception about nanotechnology hazards in korea. Environ. Toxicol. 23, 247-256 (2008).
72. Takahashi, H. et al. Modification of gold nanorods using phosphatidylcholine to reduce cytotoxicity. Langmuir22, 2-5 (2006).
73. Eghtedari, M., Liopo, A. V., Copland, J. A., Oraevsky, A. A. & Motamedi, M. Engineering of heterofunctional gold nanorods for the in vivo molecular targeting of breast cancer cells. Nano. Lett. 9, 287-291 (2009).
74. Zhang, G. et al. Influence of anchoring ligands and particle size on the colloidal stability and in vivo biodistribution of polyethylene glycol-coated gold nanoparticles in tumor-xenografted mice. Biomaterials30, 1928-1936 (2009).
75. Cho, W. S. et al. Acute toxicity and pharmacokinetics of 13nm-sized PEG-coated gold nanoparticles. Toxicol. Appl. Pharmacol. 236, 16-24 (2009).
76. Cho, W. S., Kim, S., Han, B. S., Son, W. C. & Jeong, J. Comparison of gene expression profiles in mice liver following intravenous injection of 4 and 100 nmsized PEG-coated gold nanoparticles. Toxicol. Lett. 191, 96-102 (2009).
77. Lipka, J. et al. Biodistribution of PEG-modified gold nanoparticles following intratracheal instillation and intravenous injection. Biomaterials31, 6574-6581 (2010).
78. De Jong, W. H. et al. Particle size-dependent organ distribution of gold nanoparticles after intravenous administration. Biomaterials29, 1912-1919 (2008).
79. Wang, C. W. et al. Surface modified gold nanorods for specific cell targeting. J. Korean Phys. Soc. (in press).
80. Kim, B. Y., Rutka, J. T. & Chan, W. C. Nanomedicine. N. Engl. J. Med. 363, 2434-2443 (2010).
81. Stern, J. M. & Cadeddu, J. A. Emerging use of nanoparticles for the therapeutic ablation of urologic malignancies. Urol. Oncol. 26, 93-96 (2008).
82. Libutti, S. K. et al. Phase I and pharmacokinetic studies of CYT-6091, a novel PEGylated colloidal goldrhTNF nanomedicine. Clin. Cancer Res. 16, 6139-6149 (2010).
83. Libutti, S. K. TNF-Bound Colloidal Gold in Treating Patients With Advanced Solid Tumors, http://clinicaltrials. gov/ct2/show/NCT00356980 (2011).
84. Paciotti, G. F. et al. Colloidal gold: a novel nanoparticle vector for tumor directed drug delivery. Drug Deliv. 11, 169-183 (2004).
85. Lee, S., Mayer, K. M. & Hafner, J. H. Improved localized surface plasmon resonance immunoassay with gold bipyramid substrates. Anal. Chem. 81, 4450-4455 (2009).
86. Mayer, K. M. et al. A label-free immunoassay based upon localized surface plasmon resonance of gold nanorods. ACS Nano. 2, 687-692 (2008).
87. Pan, Y. et al. Size-dependent cytotoxicity of gold nanoparticles. Small3, 1941-1949 (2007).
88. Pernodet, N. et al. Adverse effects of citrate/gold nanoparticles on human dermal fibroblasts. Small2, 766-773 (2006).
89. Tkachenko, A. G. et al. Cellular trajectories of peptide-modified gold particle complexes: comparison of nuclear localization signals and peptide transduction domains. Bioconjug Chem. 15, 482-490 (2004).
90. Pan, Y. et al. Gold nanoparticles of diameter 1. 4 nm trigger necrosis by oxidative stress and mitochondrial damage. Small5, 2067-2076 (2009).
91. Tsoli, M., Kuhn, H., Brandau, W., Esche, H. & Schmid, G. Cellular uptake and toxicity of Au55 clusters. Small1, 841-844 (2005).
92. Connor, E. E., Mwamuka, J., Gole, A., Murphy, C. J. & Wyatt, M. D. Gold nanoparticles are taken up by human cells but do not cause acute cytotoxicity. Small1, 325-327 (2005).
93. Patra, H. K., Banerjee, S., Chaudhuri, U., Lahiri, P. & Dasgupta, A. K. Cell selective response to gold nanoparticles. Nanomedicine3, 111-119 (2007).
94. Khan, J. A., Pillai, B., Das, T. K., Singh, Y. & Maiti, S. Molecular effects of uptake of gold nanoparticles in HeLa cells. Chembiochem8, 1237-1240 (2007).
95. Villiers, C., Freitas, H., Couderc, R., Villiers, M. B. & Marche, P. Analysis of the toxicity of gold nano particles on the immune system: effect on dendritic cell functions. J. Nanopart. Res. 12, 55-60 (2010).
96. Loo, C. et al. Nanoshell-enabled photonics-based imaging and therapy of cancer. Technol. Cancer Res. Treat. 3, 33-40 (2004).
97. Loo, C., Lowery, A., Halas, N., West, J. & Drezek, R. Immunotargeted nanoshells for integrated cancer imaging and therapy. Nano. Lett. 5, 709-711 (2005).
98. Salem, A. K., Searson, P. C. & Leong, K. W. Multifunctional nanorods for gene delivery. Nat. Mater. 2, 668-671 (2003).
99. Niidome, T. et al. PEG-modified gold nanorods with a stealth character for in vivo applications. J. Control. Release114, 343-347 (2006).
100. Hauck, T. S., Ghazani, A. A. & Chan, W. C. Assessing the effect of surface chemistry on gold nanorod uptake, toxicity, and gene expression in mammalian cells. Small4, 153-159 (2008).
101. Gu, Y. J. et al. Nuclear penetration of surface functionalized gold nanoparticles. Toxicol. Appl. Pharmacol. 237, 196-204 (2009).
102. Zhang, X. D. et al. Toxicologic effects of gold nanoparticles in vivo by different administration routes. Int. J. Nanomedicine5, 771-781 (2010).
103. Hainfeld, J. F., Slatkin, D. N., Focella, T. M. & Smilowitz, H. M. Gold nanoparticles: a new X-ray contrast agent. Br. J. Radiol. 79, 248-253 (2006).
104. Chen, Y. S., Hung, Y. C., Liau, I. & Huang, G. S. Assessment of the in vivo toxicity of gold nanoparticles. Nanoscale Res. Lett. 4, 858-864 (2009).
105. Balasubramanian, S. K. et al. Biodistribution of gold nanoparticles and gene expression changes in the liver and spleen after intravenous administration in rats. Biomaterials31, 2034-2042 (2010).
106. Balogh, L. et al. Significant effect of size on the in vivo biodistribution of gold composite nanodevices in mouse tumor models. Nanomedicine3, 281-296 (2007).